MarketInOut Stock Screener Log In | Sign Up
 

Bioventus Inc Cl A

NASDAQ • Healthcare • Medical Devices • Quote as of 07/24/2026
Bioventus Inc Cl A stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization784.52 mln
Float33.31 mln
Earnings Date08/11/2026

EPS

0.39
Overpriced

P / E

30.26
Overvalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.94
Likely reliable

Relative Strength

60 / 100
Outperforming

Debt / Equity

1.44
Elevated leverage

Business Description

Bioventus Inc., founded in 2011 and based in Durham, North Carolina, develops and sells medical products designed to reduce pain, support bone healing, and treat conditions affecting muscles, joints, and the spine. Its offerings range from joint injections and bone grafts to surgical tools and nerve stimulation devices, serving patients across the United States and in international markets. The company distributes its products through hospitals, physicians, and various reseller channels.

Key Fundamentals

EPS0.39
P/E30.26
ROE16.78
RPS8.33
ROIC11.21
ROA4.15
Interest Cover2.58
EBITDA, mln103
EV / EBITDA9.14
EV / EBIT16.58
Revenue, mln576
EV / Revenue1.64

Financial Strength

Altman Z-Score1.6
Piotroski F-Score 8 / 9
Beneish M-Score-2.94
Price to Intrinsic Value2.02
Short Ratio3.11
Short % of Float4.71

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.16% 31 / 100   
1 Month 24.21% 97 / 100   
2 Months 13.35% 84 / 100   
6 Months 44.79% 94 / 100   
1 Year 82.38% 93 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us